Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00565916 · ClinicalTrials.gov registry record · NA
Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT00565916 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 22 participants.
The verdict
NCT00565916, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Estrogen and progesterone are two main female sex hormones. When a woman goes through menopause, the body's production of estrogen and progesterone significantly decreases. Recent studies have shown that the breakdown of fatty acids in cardiac muscle is important in maintaining a healthy heart, and that estrogen may enhance this process. Also, cardiovascular disease (CVD) occurs more frequently in postmenopausal women than in premenopausal women. This study will determine in postmenopausal women whether estrogen increases the heart's ability to use fats as energy and whether progesterone decreases this effect.
Interventions
- DRUG Placebo
- DRUG Progesterone
- DRUG Estrogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2004-08 |
| Est. Completion | 2008-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00565916
The ClinicalTrials.gov registry entry for NCT00565916 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00565916 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00565916 about?
NCT00565916 is a clinical study titled "Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism". Estrogen and progesterone are two main female sex hormones. When a woman goes through menopause, the body's production of estrogen and progesterone significantly decreases. Recent studies have shown that the breakdown of fatty acids in cardiac muscle is important in maintaining a healthy heart, and ...
What is the current status of trial NCT00565916?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2004-08. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00565916?
The interventions under investigation include: Placebo (DRUG), Progesterone (DRUG), Estrogen (DRUG).
Who is sponsoring clinical trial NCT00565916?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.